Patents by Inventor Ulrich Kautz

Ulrich Kautz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
    Patent number: 9962377
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of areata, endogenous acne, exogenous acne or acne rosacea.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: May 8, 2018
    Assignee: TAKEDA GMBH
    Inventor: Ulrich Kautz
  • NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS
    Publication number: 20160279120
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of areata, endogenous acne, exogenous acne or acne rosacea.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Inventor: Ulrich KAUTZ
  • Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
    Patent number: 9387205
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of atopic eczema.
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: July 12, 2016
    Assignee: TAKEDA GMBH
    Inventor: Ulrich Kautz
  • NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS
    Publication number: 20150352096
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of atopic eczema.
    Type: Application
    Filed: August 25, 2015
    Publication date: December 10, 2015
    Inventor: Ulrich KAUTZ
  • Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
    Patent number: 9149479
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of psoriasis.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: October 6, 2015
    Assignee: Takeda GmbH
    Inventor: Ulrich Kautz
  • NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS
    Publication number: 20150119389
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of psoriasis.
    Type: Application
    Filed: October 7, 2014
    Publication date: April 30, 2015
    Inventor: Ulrich KAUTZ
  • 3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives
    Patent number: 9018175
    Abstract: The compounds of Formula (1), in which A, R1, R2, R3 and R5 have the meanings as given in the description, are novel effective inhibitors of type 4 and 5 phosphodiesterase.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: April 28, 2015
    Assignee: Takeda GmbH
    Inventors: Dieter Flockerzi, Thomas Stengel, Alexander Mann, Harald Ohmer, Ulrich Kautz, Steffen Weinbrenner, Stefan Fischer, Christof Zitt, Armin Hatzelmann, Torsten Dunkern, Christian Hesslinger, Thomas Maier, Hermann Tenor, Clemens Braun, Raimund Külzer, Degenhard Marx
  • Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
    Patent number: 8883818
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of atopic eczema.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: November 11, 2014
    Assignee: Takeda GmbH
    Inventor: Ulrich Kautz
  • Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
    Patent number: 8829189
    Abstract: Disclosed herein are salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: September 9, 2014
    Assignee: Takeda GmbH
    Inventors: Ulrich Kautz, Matthias Webel, Christian Scheufler, Rolf-Peter Hummel
  • Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
    Patent number: 8754218
    Abstract: Disclosed herein are salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: June 17, 2014
    Assignee: Takeda GmbH
    Inventors: Ulrich Kautz, Matthias Webel, Christian Scheufler, Rolf-Peter Hummel
  • NOVEL 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO[4,3-C] ISOQUINOLINE COMPOUNDS
    Publication number: 20140113877
    Abstract: The compounds of formula (1) in which A, X, R1, R2, R3 and R7 have the meanings as given in the description, are novel effective inhibitors of type 4 and type 5 phosphodiesterase.
    Type: Application
    Filed: June 12, 2012
    Publication date: April 24, 2014
    Applicant: Takeda GmbH
    Inventors: Dieter Flockerzi, Alexander Mann, Thomas Stengel, Harald Ohmer, Ulrich Kautz, Steffen Weinbrenner, Stefan Fischer, Hermann Tenor, Christof Zitt, Armin Hatzelmann, Torsten Dunkern, Christian Hesslinger, Clemens Braun, Ewald Benediktus, Andreas Pahl, Raimund Kuelzer, Degenhard Marx
  • NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS
    Publication number: 20140073636
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of atopic eczema.
    Type: Application
    Filed: April 30, 2013
    Publication date: March 13, 2014
    Applicant: TAKEDA GMBH
    Inventor: Ulrich KAUTZ
  • NOVEL SALTS OF 6-HETEROCYCLE SUBSTITUTED HEXAHYDROPHENANTHRIDINE DERIVATIVES
    Publication number: 20140039001
    Abstract: Disclosed herein are salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions.
    Type: Application
    Filed: October 11, 2013
    Publication date: February 6, 2014
    Applicant: TAKEDA GMBH
    Inventors: Ulrich KAUTZ, Matthias WEBEL, Christian SCHEUFLER, Rolf-Peter HUMMEL
  • Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
    Patent number: 8455653
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of psoriasis.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: June 4, 2013
    Assignee: Takeda GmbH
    Inventor: Ulrich Kautz
  • Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
    Patent number: 8354535
    Abstract: The invention relates to salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical composition for use, e.g., in treatment of airway disorders.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: January 15, 2013
    Assignee: Nycomed GmbH
    Inventors: Ulrich Kautz, Matthias Webel, Christian Scheufler, Rolf-Peter Hummel
  • Guanidinyl-substituted hydroxy-6-phenylphenanthridines
    Patent number: 8329906
    Abstract: The compounds of a certain formula (1), in which R1, R2, R3, R31, R4, R5, R6 and R7 have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Grant
    Filed: July 27, 2009
    Date of Patent: December 11, 2012
    Assignee: Nycomed GmbH
    Inventor: Ulrich Kautz
  • Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
    Patent number: 8324391
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors.
    Type: Grant
    Filed: May 19, 2011
    Date of Patent: December 4, 2012
    Assignee: Nycomed GmbH
    Inventor: Ulrich Kautz
  • Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
    Patent number: 8318944
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors.
    Type: Grant
    Filed: May 19, 2011
    Date of Patent: November 27, 2012
    Assignee: Nycomed GmbH
    Inventor: Ulrich Kautz
  • 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES
    Publication number: 20120289474
    Abstract: The compounds of Formula (1), in which A, R1, R2, R3 and R5 have the meanings as given in the description, are novel effective inhibitors of type 4 and 5 phosphodiesterase.
    Type: Application
    Filed: December 15, 2010
    Publication date: November 15, 2012
    Applicant: NYCOMED GMBH
    Inventors: Dieter Flockerzi, Thomas Stengel, Alexander Mann, Harald Ohmer, Ulrich Kautz, Steffen Weinbrenner, Stefan Fischer, Christof Zitt, Armin Hatzelmann, Torsten Dunkern, Christian Hesslinger, Thomas Maier, Hermann Tenor, Clemens Braun, Raimund Külzer, Degenhard Marx
  • 3-hydroxy-6-phenylphenanthridines as PDE4 inhibitors
    Patent number: 8202880
    Abstract: The compounds of formula I in which R1, R2, R3, R31, R4, R5, R6 and R7 have the meanings as indicated in the description, are novel effective PDE4 inhibitors.
    Type: Grant
    Filed: August 27, 2008
    Date of Patent: June 19, 2012
    Assignee: NYCOMED GmbH
    Inventors: Ulrich Kautz, Beate Schmidt